semaglutide effects on kidneys and kidney disease FLOW clinical Trial (funded by Novo Nordisk): showed 24% reduction in Ozempic: Semaglutide is a GLP-1

Have a BMI of 30 or more with metabolic diseases like type 2 diabetes

Predisposition data does not guarantee side-effect severity or medication response

This is the key building block your body uses to produce glutathione naturally

GLP-1 medications work best for Jacksonville and Ponte Vedra area residents who have BMI of 30+ (or 27+ with weight-related health conditions like diabetes or hypertension), have struggled to lose weight through diet and exercise alone, are ready to commit to healthier eating and lifestyle habits, and want medically supervised treatment with proven effectiveness

Franco, A

Better HbA1c control can support long-term diabetes management and may help reduce the risk of complications when used as part of a full treatment plan